Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.69 USD | +8.53% | +0.82% | -58.02% |
Apr. 26 | AbbVie raises annual profit forecast on strong Skyrizi sales | RE |
Apr. 12 | Revance Therapeutics, Inc. to Present New DAXXIFY Data at the American Academy of Neurology 2024 Annual Meeting | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.02% | 354M | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-14.82% | 15.36B | |
-8.82% | 11.95B | |
-16.29% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- Top Midday Decliners